Experience

Davis Polk is advising UBS AG London Branch as sponsor in connection with the unification of Unilever’s dual-headed group legal structure under a single parent company, Unilever PLC, to be…

Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of 5,500,000 American Depositary Shares of BioNTech SE. In addition,…

Davis Polk advised the joint book-running managers on an offering by Wyndham Destinations, Inc. of $650 million aggregate principal amount of its 6.625% senior secured notes due…

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by InflaRx N.V. of its shares of common stock for up to an aggregate amount of $50…

Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…

Davis Polk advised Centogene N.V. on its $49 million follow-on public offering of 3,500,000 of its common shares, consisting of 2,000,000 common shares offered by Centogene and 1,500,000…

Davis Polk advised the joint lead managers in connection with the Rule 144A/Regulation S offering by the Hashemite Kingdom of Jordan of $500 million aggregate principal amount of its 4.950%…

Davis Polk advised the joint global coordinators of a private placement of new ordinary shares of Harmony Gold Mining Company Limited, representing approximately 11.100% of its issued…

Davis Polk advised the lead managers in connection with a Rule 144A/Reg S green bond offering by ING Groep N.V. of $1 billion aggregate principal amount of 1.400% callable fixed-to-fixed…

Davis Polk advised Oryzon Genomics, S.A. on its private placement of approximately 7,273,000 of its ordinary shares pursuant to a capital increase. The offering consisted of two tranches: a…